The First Affiliated Hospital of Zhengzhou University
OrganisationROR
Trials
Phase 2, Not yet recruiting, 34 people, 18 Sept 2026
Status unknown, 33 people, 17 Sept 2026
Early phase 1, Recruiting, 69 people, 1 Aug 2026
Phase 3, Not yet recruiting, 586 people, 1 Jun 2026
Phase 3, Not yet recruiting, 564 people, 20 Apr 2026
Phase 3, Not yet recruiting, 578 people, 3 Mar 2026
Collaborator, Not yet recruiting, 150 people, 22 Sept 2025
Phase 2, Recruiting, 29 people, 5 Aug 2025
Collaborator, Phase 4, Recruiting, 200 people, 3 Aug 2025
Phase 2, Not yet recruiting, 33 people, 25 Jul 2025
Phase 1, Recruiting, 80 people, 26 Mar 2025
Phase 2, Recruiting, 276 people, 21 Aug 2024
Collaborator, Phase 2/3, Recruiting, 96 people, 20 Aug 2024
Phase 2, Recruiting, 170 people, 16 Aug 2024
Phase 2, Not yet recruiting, 42 people, 3 Jun 2024
Phase 2, Status unknown, 45 people, 9 Jun 2023
Phase 2, Not yet recruiting, 25 people, 3 May 2023
Collaborator, Phase 3, Recruiting, 80 people, 21 Apr 2023
Collaborator, Phase 4, Status unknown, 1,000 people, 21 Dec 2022
Collaborator, Phase 1, Status unknown, 19 people, 12 Oct 2022
Sources: trialsearch.who.int
Funded papers
Loss of PINK1 impairs mitophagy and accelerates ovarian aging independent of Parkin
QNCXTD2023017, 16 Feb 2026
Initial and cyclic recruitment of ovarian follicles: a quarter-century update
QNCXTD2023017, 18 Jun 2025
Sources: api.crossref.org